US2011269165A1PendingUtilityA1

Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same

Assignee: TSUJI NORIKOPriority: Nov 28, 2003Filed: Nov 10, 2009Published: Nov 3, 2011
Est. expiryNov 28, 2023(expired)· nominal 20-yr term from priority
A61P 37/02A61P 37/08A61P 1/04A23K 10/16A23K 10/18A61K 35/744A23L 33/135C12R 2001/46C12N 1/205A23C 19/0323A23V 2400/231
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

To provide a microorganism and an ingredient thereof that contribute to prevention and treatment of immune diseases including allergy, autoimmune diseases and inflammatory bowel diseases (e.g., large-intestinal ulcer), a method of effectively selecting the microorganism, and a method of efficiently inducing immunoregulatory cells that play an important role on maintaining immunological homeostasis using the microorganism or the ingredient thereof. The present invention provides a Lactococcus and an ingredient thereof which induce production of IL-b from mammalian dendritic or spleen cells, a method of obtaining the microorganism or the ingredient thereof by co-culturing a microorganism such as Lactococcus strains with mammalian dendritic or spleen cells to select a microbial cell having a high IL-b production ability, a method of selecting the microorganism or the ingredient thereof by co-culturing an intestinal epithelial cell with a microorganism such as the lactic acid bacteria and selecting the cells on the basis of a caspase-1 activity and the ability of inducing the production of IL-18, and a food product or material and an animal feeding stuff or medical and pharmaceutical products which contain the lactic acid bacteria as an effective ingredient.

Claims

exact text as granted — not AI-modified
1 . A method of obtaining a microorganism or its cellular components having an immunoregulatory function derived from the microorganism, which induces production of Interleukin-10 from mammalian dendritic or spleen cells, comprising:
 co-culturing a bacterium to be tested with the mammalian dendritic or spleen cell; and   selecting a microbial strain having an ability of inducing the production of Interleukin-10.   
     
     
         2 . A method of obtaining a microorganism or its cellular components having an immunoregulatory function of  claim 1 , wherein the bacterium to be tested is a  Lactococcus.    
     
     
         3 . A method of selecting a microorganism or its cellular components having an immunoregulatory function, which induces the production of Interleukin-10 from mammalian dendritic or spleen cells, comprising:
 co-culturing cells to be tested with intestinal epithelial cells to induce cells having a low ability of inducing caspase-I activity and an enhanced ability of inducing the production of Interleukin-18.

Join the waitlist — get patent alerts

Track US2011269165A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.